Puberty Blockers for Children: Can They Consent?

Area of Science:

• Pediatric endocrinology
• Child and adolescent psychiatry
• Gender studies

Background:

• Increasing referrals for gender dysphoria, often rapid in onset and predominantly in natal females.
• Pre-existing mental health issues are common in individuals with gender dysphoria.
• Current clinical practices involve puberty blockers to pause puberty, despite known side effects.

Purpose of the Study:

• To critically review the prevailing culture of affirming gender dysphoria in children.
• To evaluate the appropriateness and long-term implications of using puberty blockers in minors.
• To assess the capacity of children to consent to medical interventions for gender dysphoria.

Main Methods:

• Literature review and critical analysis of existing research on gender dysphoria and its treatments.
• Examination of the effects of puberty blockers on mental health and physical development.
• Analysis of the concept of informed consent in relation to pediatric interventions.

Main Results:

• Puberty blockers have serious side effects and uncertain long-term outcomes, with no demonstrated improvement in mental health.
• Without intervention, a significant majority of children naturally desist from gender dysphoria.
• Over 90% of those treated with puberty blockers proceed to irreversible hormonal and surgical interventions.
• The immature cognitive and emotional state of children raises concerns about their ability to understand long-term consequences.

Conclusions:

• The current affirmation-only approach to gender dysphoria in children warrants critical review.
• Children lack the capacity to provide informed consent for treatments like puberty blockers due to developmental immaturity.
• The long-term consequences of puberty blockers and subsequent interventions are irreversible and potentially harmful.